Published by Coherent Market Insights
Posted on September 28, 2021
7 min readLast updated: February 1, 2026
The NIPT market is growing due to increased awareness and prevalence of chromosomal disorders, with a forecasted value of US$ 1,936.4 Mn by 2027.
Non-invasive prenatal testing (NIPT) is a DNA test on maternal blood to screen pregnancies for the most common fetal chromosome anomalies such as trisomy 21 that is Down syndrome, trisomy 18 Edwards syndrome and trisomy 13 Patau syndrome. During non-invasive prenatal testing DNA from the mother and fetus is extracted from maternal blood sample and it is recommended for women who have risk factors for having a baby who has a chromosomal condition. Increasing launches and approvals of new non-invasive prenatal tests (NIPT) along with increasing prevalence of chromosomal disorders is expected to propel the market growth during the forecasted period.
Key Players Profiled in the Non-invasive Prenatal Testing (NIPT) Market Report are as follows: Ariosa Diagnostics, Inc., BGI Diagnosis Co., Ltd., Berry Genomics Corporation, Illumina, Inc., LifeCodexx AG, Natera, Inc., Sequenom, Inc., Natera, Inc., Axia Women’s Health, Eluthia, BillionToOne, Inc., and Quest Diagnostics Incorporated.
Request Sample Copy of Non-invasive Prenatal Testing (NIPT) Report @
https://www.coherentmarketinsights.com/insight/request-sample/579
The global non-invasive prenatal testing market was valued at US$ 882.9 Mn in 2019 and is forecast to reach a value of US$ 1,936.4 Mn by 2027 at a CAGR of 10.3% between 2020 and 2027.
High prevalence of chromosomal disorders is expected to propel growth of the global non-invasive prenatal testing market over the forecast period. For instance, according to the study, ‘Estimating Nationwide Prevalence of Live Births with Down Syndrome and Their Medical Expenditures in Korea’, published in Journal of Korean Medical Science in August 2019, the prevalence of live births with Down’s syndrome was 5.03 per 10,000 births between 2007 and 2016.
Moreover, high awareness regarding benefits of non-invasive testing methods is also expected to aid in growth of the global non-invasive prenatal testing market. Obstetricians are increasingly recommending patients to undergo non-invasive tests as an alternative to invasive methods and initial diagnostic screening in the first trimester of a pregnancy.
Enquiry Before Buying This Report:
https://www.coherentmarketinsights.com/insight/talk-to-analyst/579
Why You Should Buy This Report?
• To gain an in-depth understanding of Non-invasive Prenatal Testing (NIPT) market globally
• To identify the on-going trends and anticipated growth in the next nine years
• To help industry consultants, Non-invasive Prenatal Testing (NIPT) market other stakeholders align their market-centric strategies
• To obtain research-based business decisions and add weight to presentations and marketing strategies
• To gain competitive knowledge of leading market players
Request for Customization:
https://www.coherentmarketinsights.com/insight/request-customization/579
The report answers questions such as:
• What is the market size and forecast of the Non-invasive Prenatal Testing (NIPT) market?
• What are the inhibiting factors and impact of COVID-19 shaping the Non-invasive Prenatal Testing (NIPT) market during the forecast period?
• Which are the products/segments/applications/areas to invest in over the forecast period in the Non-invasive Prenatal Testing (NIPT) market?
• What is the competitive strategic window for opportunities in the Non-invasive Prenatal Testing (NIPT) market?
• What are the technology trends and regulatory frameworks in the Non-invasive Prenatal Testing (NIPT) market?
• What are the modes and strategic moves considered suitable for entering the Non-invasive Prenatal Testing (NIPT) market?
Note: Access insightful study with over 150+ pages, list of tables & figures, profiling 20+ companies.
Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.
Contact us:
Mr. Shah
Senior Client Partner – Business Development
sales@coherentmarketinsights.com
www.coherentmarketinsights.com
The post Non-invasive Prenatal Testing (NIPT) Market – High awareness regarding benefits of non-invasive testing methods is expected to boost the growth of the market appeared first on Gatorledger.
The article discusses the growth of the Non-invasive Prenatal Testing (NIPT) market, driven by increased awareness and prevalence of chromosomal disorders.
NIPT is a non-invasive method to screen for common fetal chromosome anomalies, offering a safer alternative to invasive testing methods.
Key players include Ariosa Diagnostics, BGI Diagnosis, Berry Genomics, Illumina, LifeCodexx, Natera, Sequenom, Axia Women’s Health, Eluthia, BillionToOne, and Quest Diagnostics.
Explore more articles in the Research Reports category
